Autopsy report · NCT02771925

Treatment for Alcohol Dependence With Gabapentin

“Due to poor compliance of patients in the study.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 1 year 11 months before it stopped.
• 25 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Dayanand Medical College and Hospital

Sponsor type

University, hospital or other

Conditions

Alcohol Dependence

Interventions

Gabapentin 2g/day divided in two doses for 24 weeks; Placebo 2g/day divided in two doses for 24 weeks

Participants

25

Sites

1

Countries

India

Trials that died the same way

• Inotropic Treatment With Levosimendan (SimdaxR)in Heart Surgery
  “The study was stopped due to difficulties in including patients” (73% match in meaning)
• Intra-erythrocyte Dexamethasone Versus Placebo in Patients With Steroid-dependent Crohn's Disease
  “due to the difficulty to enroll suitable patients” (70% match in meaning)
• Phase Ib/IIa Trial to Evaluate Oregovomab and Nivolumab in Epithelial Cancer of Ovarian, Tubal or Peritoneal Origin
  “The study had poor efficacy.” (70% match in meaning)
• Grand Autohemo-Therapy With Oxygen-ozone on Patients With Hypertonia
  “Lack of compliance of the clinical site” (69% match in meaning)
• Propanolol and Red Cell Adhesion Non-asthmatic Children Sickle Cell Disease
  “Inability to recruit patients into the study.” (68% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.